{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"Number of patients whose disease relapsed.","groups":[{"description":"Patients receive administration of high dose cytosine arabinoside and mitoxantrone followed by hematopoietic cell transplant.","id":"OG000","title":"Cytarabine + Mitoxantrone"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 Year","title":"Patients Who Relapsed","type":"SECONDARY","unitOfMeasure":"participants"}